Skip to product information
1 of 1

Human CDK-7 (Cyclin-dependent Kinase 7) ELISA Kit

Human CDK-7 (Cyclin-dependent Kinase 7) ELISA Kit

The Human (CDK-7) Cyclin-dependent Kinase 7 ELISA Kit measures Cyclin-dependent kinase 7 in samples. The plate has been pre-coated with Human CDK-7 antibody. CDK-7 present in the sample is added and binds to antibodies coated on the wells. And then biotinylated Human CDK-7 Antibody is added and binds to CDK-7 in the sample. Then Streptavidin-HRP is added and binds to the Biotinylated CDK-7 antibody. After incubation unbound Streptavidin-HRP is washed away during a washing step. Substrate solution is then added and color develops in proportion to the amount of Human CDK-7. The reaction is terminated by addition of acidic stop solution and absorbance is measured at 450 nm.

Catalog No: E0951Hu
Regular price $595.00 USD
Regular price $458.00 USD Sale price $595.00 USD
Sale Sold out
Packaging
2.5 weeks
Download PDF

Product Details

Species Reactivity Human
Sensitivity 0.031 ng/mL
Detection Range 0.05-20 ng/mL
Sample Type Serum, plasma, cell culture supernates
Incubation(s) 1.5 hour(s)
Research Areas Cell Biology, Enzyme & Kinase
Background Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition. Source: UniProt Consortium (2025)
Shipping Condition Shipped on cold gel packs.
Storage Condition and Shelf Life 2-8C
Analyte Cyclin-dependent kinase 7
Regulatory Status For Research Use Only
View full details

Inquire about this product